Intended for healthcare professionals

  1. Principles for...
  2. Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1)
Education And Debate

Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1)

BMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7497.956 (Published 21 April 2005) Cite this as: BMJ 2005;330:956

Data supplement

Related articles

See more

Cited by...

  • Improving the transparency and reliability of observational studies through registration
  • A priori registration of global health research--necessity or absurdity?
  • Characteristics and trends of clinical studies primarily sponsored by China in WHO primary registries between 2009 and 2018: a cross-sectional survey
  • Quality assessment of clinical trial registration with traditional Chinese medicine in WHO registries
  • Clinical trials: registration and transparency
  • From Protocols to Publications: A Study in Selective Reporting of Outcomes in Randomized Trials in Oncology
  • PCORI's ambitious efforts to promote transparency and dissemination of research findings
  • Making Prospective Registration of Observational Research a Reality
  • SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
  • Unlocking Health Canadas cache of trade secrets: mandatory disclosure of clinical trial results
  • Prospective Registration of Marker Evaluation Studies: Time to Act
  • Impact of document type on reporting quality of clinical drug trials: a comparison of registry reports, clinical study reports, and journal publications
  • Registration of observational studies: Is it time?
  • Finding studies on reboxetine: a tale of hide and seek
  • Discrepancies between research advertisements and disclosure of study locations in trial registrations for USA-sponsored research in Russia
  • Registration of observational studies
  • New methods to deal with publication bias
  • Industry attack on academics
  • Discrepancies in sample size calculations and data analyses reported in randomised trials: comparison of publications with protocols
  • Clinical trials of endothelin antagonists in heart failure: publication is good for the public health
  • How should we rate research?: Cost of research should be disclosed publicly
  • Waiving confidentiality for the greater good
  • Learning from the TGN1412 trial
  • Mortality from cirrhosis: lack of progress over the last 35 years
  • Randomised controlled trials in Africa of HIV and AIDS: descriptive study and spatial distribution
  • Research from tobacco industry affiliated authors: need for particular vigilance
  • Next steps in trial registration
  • Why industry should register and disclose results of clinical studies--perspective of a recovering academic
Back to top